ZHEJIANG CHENG YI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.52 CNY | -0.13% |
|
-0.40% | -27.48% |
| Feb. 07 | Cheng Yi Pharmaceutical Shareholder Boosts Stake in Firm | MT |
| 2023 | Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2021 | 694M 95.77M | Sales 2022 | 655M 90.39M | Capitalization | 3.27B 451M |
|---|---|---|---|---|---|
| Net income 2021 | 171M 23.6M | Net income 2022 | 162M 22.36M | EV / Sales 2021 | 5.56 x |
| Net Debt 2021 | 65.22M 9M | Net Debt 2022 | 213M 29.44M | EV / Sales 2022 | 5.32 x |
| P/E ratio 2021 |
22.2
x | P/E ratio 2022 |
20.3
x | Employees | 746 |
| Yield 2021 |
1.54% | Yield 2022 |
1.79% | Free-Float | 61.24% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.13% | ||
| 1 week | -0.40% | ||
| Current month | -5.17% | ||
| 1 month | -6.35% | ||
| 3 months | -9.72% | ||
| 6 months | -31.57% | ||
| Current year | -27.48% |
1 week
7.30
7.65
1 month
7.098.26
Current year
5.7810.62
1 year
5.7814.00
3 years
5.7814.71
5 years
5.7816.07
10 years
4.9216.86
| Managers | Title | Age | Since |
|---|---|---|---|
Chun Jian Zhao
CEO | Chief Executive Officer | 47 | 18-04-22 |
Sun Zhan Lü
DFI | Director of Finance/CFO | 45 | 16-03-11 |
Shi Sheng Li
BRD | Director/Board Member | 73 | 16-03-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tao Jin
BRD | Director/Board Member | 56 | 19-05-05 |
Yi Yi Yan
CHM | Chairman | 75 | 16-03-11 |
Bing Jun Ren
BRD | Director/Board Member | 58 | 16-03-11 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 7.52 | -0.13% | 2,533,875 |
| 24-04-19 | 7.53 | +0.67% | 2,182,228 |
| 24-04-18 | 7.48 | 0.00% | 2,800,060 |
| 24-04-17 | 7.48 | +3.89% | 3,654,636 |
| 24-04-16 | 7.2 | -4.64% | 6,547,834 |
End-of-day quote Shanghai S.E., April 21, 2024
More quotes
Zhejiang Cheng Yi Pharmaceutical Co., Ltd is a China-based company principally engaged in the research, development, production and sales of bulk pharmaceutical chemicals of chemical medicine and preparations. The Companyâs products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -27.48% | 340M | |
| +25.46% | 659B | |
| +25.81% | 557B | |
| -4.86% | 359B | |
| +16.44% | 322B | |
| +8.34% | 297B | |
| +6.23% | 215B | |
| +7.28% | 210B | |
| -6.26% | 200B | |
| -8.79% | 149B |
- Stock Market
- Equities
- 603811 Stock
